In vitro diagnostics specialists today have to design systems capable of carrying out increasingly complex tests while making the results easier to interpret. HORIBA Medical has risen to the challenge by considerably intensifying its research efforts. The company aims to invest over 10% of its sales in R&D in the medium term.
Many new concepts, that are unique, have been introduced in the field of in vitro diagnostics, including the most compact system on the market (Micros designed by HORIBA Medical).
Over 40 “key” patent families have been lodged worldwide, covering all the technologies included in our testing systems.

Key indicators

  • Over 1,100 employees
  • 5 production centers (Japan, China, France, Brazil, India)
  • 2 R&D centers (Japan, France)
  • Around 100 distributors
  • 14 local/direct operations
  • Around 30,000 laboratories supplied worldwide
Biological markers for screening

25 Jun 2020 - How routinely measured biological markers could contribute to the monitoring of Coronavirus...

Read more

World Blood Cancer Day

28 May 2020 - HORIBA UK Limited is raising awareness of the World Blood Cancer Day and shows support to people...

Read more

Microsemi CRP

26 May 2020 - Microsemi CRP haematology analysers installed during COVID-19 ‘lockdown’ in POC locations to reduce...

Read more